Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > "the boats are shaking" lol jk

<< Previous

Bullboard Posts

Next >>

Comment by Lesalpes29on Mar 04, 2024 2:38pm

110 Views

Post# 35913917

RE:RE:RE:RE:"the boats are shaking" lol jk

Speculation. But volume, drop in price we need probably an entity holding a lot of shares. If you prefer a leak or it could be ATM. Many possibilities or maybe the favorite reason of unstable... manipulation. Big joke!

<< Previous

Bullboard Posts

Next >>

Nvidia reports record revenue in Q3